“Safety, Tolerability and Efficacy of Tirbanibulin Ointment 1% Treatment on 100 Cm2 of the Face and Scalp in Patients With Actinic Keratosis: A Phase 3 Study”. SKIN The Journal of Cutaneous Medicine, vol. 7, no. 6, Nov. 2023, p. s264, https://doi.org/10.25251/skin.7.supp.264.